151 related articles for article (PubMed ID: 31937175)
21. Identification of key pathogenic genes of sepsis based on the Gene Expression Omnibus database.
Lu X; Xue L; Sun W; Ye J; Zhu Z; Mei H
Mol Med Rep; 2018 Feb; 17(2):3042-3054. PubMed ID: 29257295
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
Winnepenninckx V; van den Oord JJ
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
[TBL] [Abstract][Full Text] [Related]
23. Tumor biomarkers in melanoma.
Ugurel S; Utikal J; Becker JC
Cancer Control; 2009 Jul; 16(3):219-24. PubMed ID: 19556961
[TBL] [Abstract][Full Text] [Related]
24. Integration of protein interaction and gene co-expression information for identification of melanoma candidate genes.
Wu K; Wang W; Ye Y; Huang J; Zhou Y; Zhang Y; Zhang X; Wu W
Melanoma Res; 2019 Apr; 29(2):126-133. PubMed ID: 30451788
[TBL] [Abstract][Full Text] [Related]
25. A marker for melanoma?
Chande M
Lancet; 2001 Aug; 358(9281):565. PubMed ID: 11520537
[No Abstract] [Full Text] [Related]
26. Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling.
Busam KJ; Zhao H; Coit DG; Kucukgol D; Jungbluth AA; Nobrega J; Viale A
J Invest Dermatol; 2005 Feb; 124(2):412-8. PubMed ID: 15675962
[TBL] [Abstract][Full Text] [Related]
27. Integrative Analysis of Long Noncoding RNA (lncRNA), microRNA (miRNA) and mRNA Expression and Construction of a Competing Endogenous RNA (ceRNA) Network in Metastatic Melanoma.
Wang LX; Wan C; Dong ZB; Wang BH; Liu HY; Li Y
Med Sci Monit; 2019 Apr; 25():2896-2907. PubMed ID: 31004080
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatic Analysis of Gene Expression for Melanoma Treatment.
Kawakami A; Fisher DE
J Invest Dermatol; 2016 Dec; 136(12):2342-2344. PubMed ID: 27884291
[TBL] [Abstract][Full Text] [Related]
29. Identification of microRNA expression patterns in cutaneous and uveal melanoma cell lines.
Venza M; Dell'Aversana C; Visalli M; Altucci L; Teti D; Venza I
Tumori; 2014; 100(1):e4-7. PubMed ID: 24675509
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.
Jensen EH; Lewis JM; McLoughlin JM; Alvarado MD; Daud A; Messina J; Enkemann S; Yeatman TJ; Sondak VK; Riker AI
Ann Surg Oncol; 2007 Apr; 14(4):1416-23. PubMed ID: 17195911
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Zhu Y; Wen X; Zhao P
Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
[TBL] [Abstract][Full Text] [Related]
33. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
[TBL] [Abstract][Full Text] [Related]
34. Review and cross-validation of gene expression signatures and melanoma prognosis.
Schramm SJ; Campain AE; Scolyer RA; Yang YH; Mann GJ
J Invest Dermatol; 2012 Feb; 132(2):274-83. PubMed ID: 21956122
[TBL] [Abstract][Full Text] [Related]
35. Is nonmetastatic cutaneous melanoma predictable through genomic biomarkers?
Branca M; Orso S; Molinari RC; Xu H; Guerrier S; Zhang Y; Mili N
Melanoma Res; 2018 Feb; 28(1):21-29. PubMed ID: 29194095
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatic and Machine Learning Applications in Melanoma Risk Assessment and Prognosis: A Literature Review.
Ma EZ; Hoegler KM; Zhou AE
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828357
[TBL] [Abstract][Full Text] [Related]
37. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.
Georgantas RW; Streicher K; Luo X; Greenlees L; Zhu W; Liu Z; Brohawn P; Morehouse C; Higgs BW; Richman L; Jallal B; Yao Y; Ranade K
Pigment Cell Melanoma Res; 2014 Mar; 27(2):275-86. PubMed ID: 24289491
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling in melanoma: past results and future potential.
Knackstedt RW; Knackstedt T; Gastman B
Future Oncol; 2019 Mar; 15(7):791-800. PubMed ID: 30453756
[TBL] [Abstract][Full Text] [Related]
40. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]